European Society of Cardiology

The latest news from the ESC Congress, with physician perspective, researcher interviews and clinician insight.

Meeting NewsPerspective

Remote patient management improves HF outcomes: TIM-HF2

August 28, 2018
MUNICH — A structured remote patient management intervention for patients with HF reduced percentage of days lost from unplanned CV hospital…
Meeting NewsPerspective

High-STEACS: Troponin assay fails to reduce subsequent MI, CV death

August 28, 2018
MUNICH — The use of a high-sensitivity cardiac troponin I assay with a 99th centile diagnostic threshold failed to reduce subsequent MI or CV…
Meeting NewsPerspective

POET: Oral antibiotics viable residual treatment for left-sided endocarditis

August 28, 2018
MUNICH — Patients with left-sided infective endocarditis who after stabilization received treatment with oral antibiotics had similar outcomes…
Meeting NewsPerspective

PURE: Moderate red meat, dairy intake may help reduce mortality, CV risk

August 28, 2018
MUNICH — A new diet quality tool based on an analysis of more than 218,000 adults worldwide suggests that increased intake of unprocessed red…
Meeting NewsPerspective

BASKET-SMALL 2: Coronary DCB noninferior to DES in small vessels

August 28, 2018
MUNICH — In patients with small vessels with native CAD, a drug-coated balloon was noninferior to drug-eluting stents for major adverse cardiac…
Meeting NewsPerspective

FUTURE confirms link between FFR-guided treatment, mortality

August 28, 2018
MUNICH — Consistent with a previous analysis of the FUTURE trial, use of fractional flow reserve, compared with angiography, to guide treatment…
Meeting NewsPerspective

COMMANDER HF: Low-dose rivaroxaban not effective in HF with sinus rhythm and CAD

August 27, 2018
MUNICH — Low-dose rivaroxaban, when added to guideline-based therapy, did not improve all-cause mortality, MI or stroke, nor did it favorably…
Meeting NewsPerspective

Novel therapy offers benefit for rare transthyretin amyloid cardiomyopathy

August 27, 2018
MUNICH — Treatment with tafamidis reduced risk for all-cause mortality and CV-related hospitalizations in patients with hereditary and…
Meeting NewsPerspective

GLOBAL LEADERS: Long-term ticagrelor monotherapy not superior to standard DAPT

August 27, 2018
MUNICH — In patients who undergo PCI, 1 month of combination ticagrelor and aspirin therapy followed by ticagrelor alone was not superior to…
Meeting NewsPerspective

MITRA-FR: MitraClip does not change prognosis in HFrEF, mitral regurgitation

August 27, 2018
MUNICH — In patients with HF with reduced ejection fraction and secondary mitral valve regurgitation, percutaneous mitral valve repair plus…